Take Action in Support of Federal Research Funding
ASH continues to lead advocacy on behalf of hematologists in Washington as the new Administration issues executive orders and Congress works to finalize Fiscal Year 2025 federal research funding. ASH is calling on you to help support this critical advocacy.
With Congress unable to complete work on any spending measures prior to the start of the 2025 fiscal year (FY) that began on October 1, congressional leaders passed – and President Biden signed into law – a temporary funding measure to avoid a government shutdown. Also known as a continuing resolution (CR), this temporary funding measure will keep the federal government operating at FY 2024 spending levels through March 14.
Additionally, President Trump has issued a number of executive actions impacting research and public health that have created uncertainty, confusion, and extreme concern among the research community.
As Congress works to finalize FY 2025 funding for NIH and other important research and public health programs, lawmakers need to hear from constituents about the impact this funding – and executive actions – has on hematology. Please take the following steps to help:
Share Your Story – Take ASH’s anonymous survey about how recent executive orders have affected patients with hematologic conditions and hematology research. ASH plans to share these real-world examples with members of Congress and the Administration.
Contact Congress – Enter your information below to quickly send a message to your elected officials about the importance of sustained funding for NIH and other federal health programs. Please modify the letter to provide examples of why this funding is so important in your district and state. Make an even bigger impact by calling your Member of Congress and sharing the key points outlined below. Connect with your elected officials through the United States Capitol switchboard at 202-224-3121.